U.S. researchers reported on Tuesday, July 14, that Moderna’s COVID-19 vaccine candidate showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study. Subscribe to our official YouTube channel, Be the first to…